Dermorphinin humans Dermorphin peptide has garnered significant attention in the scientific community due to its remarkable potency and unique origin. This peptide is a naturally occurring opiate-like peptide that has been isolated from the skin of certain South American frogs.The dermorphin analog peptide binds to mu-opioid and delta-opioid receptorswith higher affinity and selectivity than morphin. Like other opioid agonists, ... Its discovery and subsequent research have shed light on a new class of potent opioid peptides with significant pharmacological implications.
The journey of dermorphin began with the exploration of amphibian skin secretions. Researchers first identified dermorphin in the skin of frogs belonging to the *Phyllomedusa* genus, particularly *Phyllomedusa sauvagei*, native to the Amazon rainforest. This makes dermorphin a fascinating example of a peptide expressed by the frog venom skin glands. It was first isolated in the early 1980s, and since then, numerous studies have explored its properties. Dermorphin is a hepta-peptide, meaning it is composed of seven amino acidsThe dermorphin peptide family.. Specifically, its sequence is Tyr-D-Ala-Phe-Gly-Tyr-Pro-Ser-NH2. A key distinguishing feature of dermorphin is the presence of a D-amino acid (D-Ala) in its structure, which is uncommon in mammalian peptides and contributes to its stability and potency.
The primary characteristic that sets dermorphin apart is its extraordinary affinity and efficacy at the mu-opioid receptors (MOR). It acts as a potent and selective agonist at these receptors, which are the same targets as traditional opioids like morphine. However, dermorphin exhibits significantly higher potencyDermorphin Analog peptide[orb70600]. Purity: > 95%. Sizes Available: 5 mg. Quality Guarantee. Quality Guarantee. Explore bioreagents carefree to elevate your .... Studies have shown that dermorphin is approximately 30-40 times more potent than morphine in its analgesic effects. Some research even suggests it can be over 200 times stronger than morphine, classifying it as a potent antinociceptive agent.
This high potency is attributed to its unique structure and its ability to bind with high selectivity to the mu-opioid receptors. In fact, dermorphin is considered the most selective of all m-opioid agonists identified to date. This selectivity means it primarily interacts with MORs, potentially leading to a different side effect profile compared to less selective opioids, although research in this area is ongoing.
The potent analgesic properties of dermorphin peptide have led to extensive research into its potential therapeutic applications. Its ability to bind to mu-opioid receptors and inhibit pain signals makes it a candidate for pain management. Dermorphin has demonstrated long-lasting antinociceptive activity, meaning it can provide pain relief for an extended period.
Research has explored the use of dermorphin for various types of pain, including:
* Analgesic effects: As mentioned, its primary function is to relieve pain.
* Antinociceptive effects: This refers to the inhibition of pain perceptionDermorphin peptide.
* Neuropathic pain: Dermorphin has shown promise in inhibiting neuropathic pain, a complex type of pain that arises from damage to the nervous system.
* Neuralgia: It is used to inhibit neuralgia, which is pain that follows the path of a nerve.
Furthermore, dermorphin peptides are potent analgesics in rodents and primates, including man. Some studies suggest that certain dermorphins can enter the blood-brain barrier and produce central effects, which is crucial for its pain-relieving capabilities.
The discovery of dermorphin has also spurred the investigation of dermorphin analog peptides. These are synthetic or modified versions of the original peptide designed to enhance specific properties, such as increased affinity, improved bioavailability, or altered duration of action. The dermorphin analog peptide can bind to mu-opioid and delta-opioid receptors with higher affinity and selectivity than morphine.
Beyond dermorphin, other related dermorphin-like peptides have been identified in amphibian skin. For instance, three naturally occurring dermorphin-like peptides have been found in the skin of the frog *Phyllomedusa bicolor*. These discoveries highlight the richness of natural opioid compounds in the amphibian kingdom.
While dermorphin was first isolated decades ago, its full potential is still being explored. Its status as a high potency natural opiate peptide and a potent and selective natural opioid that binds as an agonist to \u03bc-opioid receptors makes it a valuable tool for researchers studying the opioid system and pain pathways.Spinal action of dermorphin, an extremely potent opioid ...
It's important to note that dermorphin is primarily used for research use only. While its potent analgesic properties are of great interest, its clinical application in humans is still under investigation and faces regulatory hurdles作者:JMK Hesselink·2018·被引用次数:25—Dermorphin, a new peptide from amphibian skin, inhibits the nociceptive thalamic neurons firing rate evoked by noxious stimuli. Neurosci Lett.. The comprehensive understanding of dermorphin's mechanism of action, its pharmacokinetics, and its safety profile are critical for its potential future therapeutic useDermorphin (acetate). The ongoing research into dermorphin and its analogs continues to expand our knowledge of natural opioid systems and offers exciting possibilities for the development of novel pain management strategies.
Join the newsletter to receive news, updates, new products and freebies in your inbox.